Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing

Chronic kidney disease (CKD) is a critical global public health problem associated with high morbidity and mortality, poorer quality of life and increased health care expenditures. CKD and its associated comorbidities are one of the most complex clinical constellations to manage. Treatments for CKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiahua, Fagbote, Christopher O, Zhuo, Min, Hawley, Chelsea E, Paik, Julie M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Diabetic Kidney Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768299/
https://www.ncbi.nlm.nih.gov/pubmed/31583087
http://dx.doi.org/10.1093/ckj/sfz100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768299/
https://www.ncbi.nlm.nih.gov/pubmed/31583087
http://dx.doi.org/10.1093/ckj/sfz100

Ejemplares similares